Zero commission on transactions
No transaction carried out under the Plonvir recommendation is charged with a transaction fee. The entire result remains on your company's balance sheet, regardless of the number of decisions made in a given month.
Plonvir analyzes cash flows in real time and recommends the allocation of free funds before they become frozen capital. No transaction is charged a commission.
The analysis preview shows the current allocation of funds according to the availability horizon and the recommended allocation of surpluses for the next settlement period - without operator intervention in the standard mode.
Two pillars distinguish Plonvir from traditional cash management: no transaction costs and continuity of analysis independent of the working hours of the finance team.
No transaction carried out under the Plonvir recommendation is charged with a transaction fee. The entire result remains on your company's balance sheet, regardless of the number of decisions made in a given month.
The model monitors cash flow and market conditions continuously, eliminating the delays that result from manually reviewing balance sheets once a week or once a month.
The system forecasts short-term cash needs and suggests investing free funds before they become capital without an assigned function.
AI recommendations are subject to approval by a designated person in the company. The model provides analysis and proposal, it does not take over the decision-making mandate of the finance team.
Plonvir was created for companies that have cash surpluses but do not have an internal team for daily market analysis. The AI model processes a company's financial data and market signals and then presents recommendations in a language that is understandable to a financial manager, not just a quantitative analyst.
Each recommendation contains a description of the assumptions, time horizon and risk level - so that the final decision can be made consciously, and not based on the numerical recommendation alone.
Implementation does not require changing the accounting or company banking system. Data is imported and analysis starts automatically in a set cycle.
The company provides statements and operating accounts. Plonvir imports flow history without manual data entry.
The algorithm identifies cyclical cash surpluses and shortages based on historical data and current liabilities.
The system presents a proposal for investing surpluses tailored to the risk profile and time horizon accepted by the company.
Items are revised in response to changes in cash flow, and recommendations are updated in the next analysis cycle.
The safety of working capital depends on the transparency of assumptions, not on a declaration of no risk. Plonvir does not guarantee profit or eliminate market risk - it limits exposure by diversifying liquidity horizons and limits set together with the person responsible for finance in the company.
Each recommendation contains a description of the risk level and the liquidity horizon of the funds, thanks to which the final decision remains with the finance team and not solely with the model.
Exposure limits can be changed at any time - the model adapts subsequent recommendations to new parameters from the next analysis cycle.
The exposure panel shows what part of the funds remains fully mobile and what part is invested in instruments with a longer horizon - allowing you to assess the company's readiness for a sudden need for cash.
The proportions are determined individually based on the limits accepted by the company.
The following scenarios describe typical business situations in which the time taken to make a decision has a direct impact on the company's financial result.
A trading company with a pronounced seasonality of sales accumulates a significant surplus of funds after the season, which usually remains in the current account until further purchases of goods. Plonvir analyzes payment deadlines to suppliers and proposes an allocation tailored to this calendar.
A manufacturing company plans to purchase a machine or expand its plant within 6-12 months. Funds reserved for this purpose cannot be frozen in long-term instruments. The model selects the allocation so that full liquidity is maintained at the moment of investment implementation.
A company increasing the scale of its operations operates with a growing volume of cash flows, which, under the traditional commission model, would mean increasing transaction costs. In the Plonvir model, the transaction cost remains zero regardless of the operation volume.
The Plonvir model does not charge a transaction commission on recommended operations. The company's revenue comes from a source other than fees from a single transaction, which allows for a zero-cost structure on the trading volume side.
The model analyzes the company's cash flow history, current liabilities and market data, and then generates a recommendation along with a description of the risk and time horizon. The final decision requires the approval of a designated person on the company's side.
Yes - no form of investing is free from market risk. Plonvir limits exposure through limits and diversification of horizons, but does not guarantee results or protect capital against loss.
The implementation time depends on the number of accounts and the format of the company's accounting data. The integration process takes place without the need to change the existing company banking system.
NO. The recommendations are advisory in nature - each operation requires approval by the person responsible for finance in the company, in accordance with previously established exposure limits.